Articles

Anti-apoptotic BCL2L2 increases megakaryocyte proplatelet formation in cultures of human cord blood

Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT
Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT
Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA
Brigham and Women’s Hospital, Harvard University, Boston, MA
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT;George E. Wahlen VAMC GRECC, Salt Lake City, UT
Boston Children’s Hospital, Harvard University, Boston, MA
Program in Molecular Medicine and Department of Internal Medicine, University of Utah, Salt Lake City, UT;Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
Vol. 104 No. 10 (2019): October, 2019 https://doi.org/10.3324/haematol.2018.204685